
EOS Health partners with U.S.-licensed, FDA-regulated pharmacies to provide compounded semaglutide injections, tailored to your starting dose and titration schedule. Clinician-supervised from intake through dose adjustments — no insurance required, no in-person visits.
GLP-1 receptor agonists are among the most effective tools in modern weight management.
Works on GLP-1 receptors in the brain to reduce hunger signals, helping you feel full longer and eat less without fighting cravings.
Enhances how your body processes glucose and utilizes stored fat, supporting sustained energy and accelerated weight loss.
Regulates blood sugar and reduces cardiovascular risk markers — benefits that extend well beyond the number on the scale.
Unlike crash diets, GLP-1 therapy helps your body preferentially burn fat while maintaining the muscle mass that keeps you strong.
A single small injection per week. No daily pills, no complicated schedules — just one moment that fits into your routine.
Board-certified physicians review your intake, personalize your starting dose, and stay accessible throughout your treatment journey.
The entire process is online. No waiting rooms, no referrals.
Answer a brief health history questionnaire online. Takes about 10 minutes. No phone call required.
A licensed physician reviews your history, approves your prescription, and personalizes your dose schedule.
Your medication ships from a U.S. pharmacy in discreet packaging. Ongoing care and dose adjustments included.
Every plan includes physician consultation, ongoing care, and expedited shipping.
All plans include physician consultation, expedited shipping, and ongoing clinical support. No membership fees.
Monthly: $299/month — billed monthly
Quarterly (Popular): $249/month — billed $747/quarter — Save $150
6-Month Supply: $219/month — billed $1,314 every 6 months — Save $480
Subscription renews automatically at your selected billing interval unless canceled before the next renewal date.
First-time GLP-1 patients receive a progressive dose schedule designed to minimize side effects as your body adjusts.
Weeks 1–4: 0.25 mg — Tolerance building Weeks 5–8: 0.5 mg — Efficacy onset Weeks 9–12: 1.0 mg — Full therapeutic dose
12-Week JumpStart Bundle: $549 — Exclusive to patients new to GLP-1 therapy.
Yes — you can transfer from another provider and continue on your current or equivalent dose. During your medical intake, you’ll indicate your current dosage so your EOS physician can match or adjust accordingly. No need to restart from the beginning.
Semaglutide mimics the GLP-1 hormone, which signals satiety to the brain and slows gastric emptying. This reduces appetite and calorie intake without relying on willpower alone. It also improves insulin sensitivity and glucose regulation, supporting overall metabolic health alongside weight loss.
Most patients notice appetite changes within the first 2–4 weeks. Meaningful weight loss typically begins in weeks 4–8. Clinical trials showed an average of 15% body weight reduction over 68 weeks. Results vary based on starting weight, adherence, diet, and activity level.
Compounded semaglutide is prepared by U.S.-licensed, FDA-regulated pharmacies under Section 503A of the Federal Food, Drug & Cosmetic Act, but is not FDA-approved for safety or efficacy. FDA-approved brand-name equivalents include Ozempic® and Wegovy® by Novo Nordisk. Your physician will discuss whether compounded semaglutide is appropriate for you.
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are most pronounced when starting or increasing dose and typically improve within a few weeks. Our JumpStart titration protocol significantly reduces their severity. Serious but rare side effects include pancreatitis and thyroid changes.
If our physician determines this treatment is not appropriate for you, you will receive a full refund for all costs incurred. Any subscription you selected will be canceled automatically. We’ll also provide guidance on alternatives that may be a better fit.
Semaglutide is administered via a small subcutaneous injection once per week, typically into the abdomen, thigh, or upper arm. The needles are very fine — most patients report minimal discomfort. Your kit includes syringes, alcohol pads, and step-by-step instructions.
“I’ve tried everything. This is the first thing that’s actually felt sustainable.”
“My energy is back. I’m not thinking about food all day anymore.”
“The intake was easy. The check-ins are what make it work.”
“My labs are better than they’ve been in years.”
“It feels like I’m finally in control again.”
Start your free consultation today. No insurance required. Results in weeks.
Get startedIndications: Semaglutide is a GLP-1 receptor agonist indicated under physician supervision to support weight management as an adjunct to a reduced-calorie diet and increased physical activity.
Contraindications: Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are allergic to semaglutide or any of its excipients.
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, and injection site reactions. Most are transient and improve with gradual dose escalation.
Serious side effects may include thyroid tumors, acute pancreatitis, hypoglycemia (especially with insulin or sulfonylureas), acute kidney injury, severe allergic reactions, and gallbladder disease.
Regulatory status: This drug is compounded by a licensed pharmacy under Section 503A of the Federal Food, Drug & Cosmetic Act pursuant to a patient-specific prescription. The FDA does not review or approve compounded medications for safety, effectiveness, or quality. This compounded formulation is not affiliated with, endorsed by, or intended to replace Ozempic® or Wegovy® by Novo Nordisk. Individual results may vary.
Pregnancy & lactation: Not recommended during pregnancy or breastfeeding. Always consult your EOS Health physician before starting, stopping, or changing your dose.